Rivaroxaban (Xarelto) Market 2018-2026: Share, Market Valuation, Sales by Region(United States, Europe, China, Japan, Southeast Asia, India, Central & South America), Application & Distribution Channel

Rivaroxaban Market Report has been prepared based on an in-depth market analysis with inputs from experts. Global Rivaroxaban Market report 2018 covers the market landscape and its growth prospects over the coming years till 2026.

Free PDF Sample Brochure @ https://decisionmarketreports.com/request-sampleproductID=983367

Rivaroxaban is an anti-coagulant medication marketed under the brand name Xarelto by Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson. The report segments the rivaroxaban market based on strength of the drug, application, distribution channel, and region. The product is segmented into 10 mg, 15 mg, and 20 mg on the basis of strength and by application, it is segmented into deep venous thrombosis and pulmonary embolism. The report on rivaroxaban is intended to target the innovators and developers to provide in-depth analysis of the present market and the expected market scenario after the patent expiration. This report compiles the global rivaroxaban market overview, dynamics, opportunities, regional analysis, and market players.

Market Dynamics

Increasing clinical trials for the expansion of present indication of rivaroxaban is expected to be the key factor driving the rivaroxaban market growth over the forecast period. For instance, as per the data of clinical trials accessed on July 2018, Swiss Paraplegic Centre was evaluating rivaroxaban for cervical spinal cord injuries, with its successful entry in phase IV. The high cost of patented drug is a major factor contributing to high revenues and compound annual growth rate (CAGR). However, patent expiration of the drug in 2021 is expected to decrease the company revenues with the entry of new entrants with generic version of the drug at lower cost. The adverse effects of the drug such as risk of bleeding in patients leading to serious and fatal conditions are expected to restrain rivaroxaban market growth. Moreover, alternative therapies such as warfarin and heparin are cheaper, as compared to rivaroxaban and are expected to hamper growth of the global rivaroxaban market.

Know More About Report @ https://decisionmarketreports.com/market-reports/983367/rivaroxaban-market

Key features of the study:
• This report provides in-depth analysis of the rivaroxaban market and provides market size (US$ Million) and compound annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global rivaroxaban market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Janssen Pharmaceuticals Inc. and Bayer AG
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion, and marketing tactics
• The global rivaroxaban market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of rivaroxaban, research and consulting firms, new entrants, and financial analysts
• Various strategy matrices used in analyzing the rivaroxaban market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

• Global Rivaroxaban Market, By Strength:
o 10 mg
o 15 mg
o 20 mg

• Global Rivaroxaban Market, By Application:
o Deep Vein Thrombosis Prophylaxis
o Pulmonary Embolism

• Global Rivaroxaban Market, By Distribution Channel:
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies

• Global Rivaroxaban Market, By Region:
o By Strength:
 10 mg
 15 mg
 20 mg
o By Application:
 Deep Vein Thrombosis Prophylaxis
 Pulmonary Embolism
 By Distribution Channel:
 Hospital Pharmacies
 Retail Pharmacies
 Online Pharmacies

• Company Profiles
o Janssen Pharmaceuticals Inc.*
 Company Overview
 Product Portfolio
 Key Highlights
 Financial Overview
 Market Strategies
o Bayer AG

Table of Contents

1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations

2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
Market Snippet, By Strength
Market Snippet, By Application
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Industry Trends
o Regulatory Scenario
o Epidemiology

4. Global Rivaroxaban Market, By Product Type, 2016 – 2026, (US$ Million)
o Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
o 10 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
o 15 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
o 20 mg
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

5. Global Rivaroxaban Market, By Application, 2016–2026, (US$ Million)
o Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
o Deep Vein Thrombosis Prophylaxis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
o Pulmonary Embolism
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

6. Global Rivaroxaban Market, By Distribution Channel, 2016–2026, (US$ Million)
o Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
o Hospitals Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

7. Global Rivaroxaban Market, By Regions, 2016–2026, (US$ Million)
o Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2026
Regional Trends
Continued…

About Us
Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us
Gasper James
304, S Jones Blvd,
Las Vegas,
NV 89107, USA

US Toll Free +18666051052
Email: sales@decisionmarketreports.com
Web: http://decisionmarketreports.com/

This release was published on openPR.